What is she best known for?
The fields of study she is best known for:
- Immune system
- Gene
- T cell
The scientist’s investigation covers issues in Immunology, FOXP3, IL-2 receptor, Cell biology and Interleukin 10.
Autoimmunity, Peripheral tolerance, Immune system, Immunopathology and IPEX syndrome are the core of her Immunology study.
Her IPEX syndrome research is multidisciplinary, relying on both Autoimmune enteropathy and Immune dysregulation.
The study incorporates disciplines such as Jurkat cells, Transcription factor and Suppressor in addition to FOXP3.
Her Cell biology study incorporates themes from In vitro, T cell, Cluster of differentiation, Transplant rejection and Perforin.
In her research on the topic of Interleukin 10, Antigen presentation and Acquired immune system is strongly related with Antigen-presenting cell.
Her most cited work include:
- Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. (1035 citations)
- Type 1 T regulatory cells. (780 citations)
- Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production (714 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Immunology, FOXP3, Immune system, T cell and Cell biology.
Her research on Immunology frequently links to adjacent areas such as Cell therapy.
Her FOXP3 research is multidisciplinary, incorporating elements of Cancer research, Immune tolerance, IPEX syndrome, Regulatory T cell and Effector.
Her Interleukin 10 study in the realm of Immune system connects with subjects such as Viral vector.
Rosa Bacchetta works mostly in the field of T cell, limiting it down to topics relating to Antigen and, in certain cases, Stem cell.
Her Cell biology research focuses on Cytokine and how it connects with LAG3 and CD49b.
She most often published in these fields:
- Immunology (61.22%)
- FOXP3 (38.78%)
- Immune system (25.85%)
What were the highlights of her more recent work (between 2017-2021)?
- FOXP3 (38.78%)
- Immune system (25.85%)
- Immunology (61.22%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in FOXP3, Immune system, Immunology, IPEX syndrome and T cell.
Her studies deal with areas such as Haematopoiesis, Cancer research, Antigen, CTLA-4 and Effector as well as FOXP3.
Rosa Bacchetta interconnects Cell culture and Cell biology in the investigation of issues within Immune system.
Her research in Cell biology focuses on subjects like Immune tolerance, which are connected to Bioinformatics and Clinical trial.
Her research in Immune dysregulation, Regulatory T cell, Flow cytometry, Autoimmunity and Peripheral tolerance are components of Immunology.
Her T cell research focuses on Reprogramming and how it relates to Cancer immunotherapy and Computational biology.
Between 2017 and 2021, her most popular works were:
- Reprogramming human T cell function and specificity with non-viral genome targeting (283 citations)
- From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation (148 citations)
- The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases. (72 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Immune system
- T cell
Her primary areas of investigation include FOXP3, Immune system, Immunology, Computational biology and Antigen.
Her biological study spans a wide range of topics, including Autoimmune enteropathy, Primary immunodeficiency, CD8 and Cell biology.
Her research investigates the connection between Cell biology and topics such as Cytometry that intersect with issues in Immune tolerance.
Her study in T cell and Acquired immune system falls within the category of Immune system.
Her study deals with a combination of Immunology and Cell counting.
Her Antigen research includes themes of Cell, Function and Effector.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
